SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-064531
Filing Date
2017-12-07
Accepted
2017-12-07 18:16:50
Documents
2
Period of Report
2017-12-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3811
2 POA DOCUMENT poa.txt EX-24.3_755855 2486
  Complete submission text file 0001209191-17-064531.txt   7694
Mailing Address 9885 TOWNE CENTRE DR SAN DIEGO CA 92121
Business Address
FLATLEY JAY T (Reporting) CIK: 0001189130 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38311 | Film No.: 171245735

Mailing Address 151 OYSTER POINT BLVD. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 866-8548
Denali Therapeutics Inc. (Issuer) CIK: 0001714899 (see all company filings)

IRS No.: 463872213 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)